摘要：2010年11月，FDA批准tesamorelin（Egrifla）用于HIV患者的脂肪代谢障碍治疗，这是一种身体不同部位，特别是肝脏、胃及其他腹部器官的脂肪增加和堆积性疾病。本品是第一个获得FDA批准用于治疗脂肪代谢障碍的药物。
注：因版权方要求，不能公开全文，如需全文，请咨询杂志社
热门期刊服务
Journal of Hydrodynamics Journal of Huazhong University of Science and Technology The Journal of China Universities of Posts and Telecommunications Journal of Genetics and Genomics Journal of Iron and Steel Research Journal of Systems Science and Complexity World Journal of Gastroenterology Journal of Computer Science and Technology Applied Mathematics:A Journal of Chinese Universities International Journal of Minerals Metallurgy and Materials International Journal of Mining Science and Technology Journal of Systems Science and Systems Engineering